QIAGEN : to embrace global initiative to combat antibiotic resistance and launches cutting-edge QIAGEN Microbial Insights AR
QIAGEN today announced a new initiative to help address the global crisis of antibiotic-resistant pathogens. The Company will commit resources to support biomarker research and participate in the U.S. Centers for Disease Control and Prevention (CDC) Antimicrobial Resistance (AMR) Challenge. As a first response, QIAGEN is launching QIAGEN Microbial Insights AR (QMI-AR), an integrated genomic database that provides curated, single-point of entry access to four of the world’s largest knowledge bases on antimicrobial resistance.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.